![Karin Heidemann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Karin Abarca Heidemann formerly worked at Rockland Immunochemicals, Inc., as Vice President-Scientific Operations from 2017 to 2019 and Champions Oncology, Inc., as Executive VP-Global Scientific Operations from 2021 to 2025.
Dr. Heidemann received her undergraduate degree from Universität zu Köln.
Ehemalige bekannte Positionen von Karin Heidemann
| Unternehmen | Position | Ende |
|---|---|---|
| CHAMPIONS ONCOLOGY, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2025 |
Rockland Immunochemicals, Inc.
 Rockland Immunochemicals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which manufactures antibodies and related reagents | Corporate Officer/Principal | 01.09.2019 |
Ausbildung von Karin Heidemann
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
1
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Universität zu Köln
 Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Champions Oncology, Inc.
 Champions Oncology, Inc. BiotechnologyHealth Technology Provides advanced technology solutions and services for oncology drugs | Health Technology |
Rockland Immunochemicals, Inc.
Rockland Immunochemicals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which manufactures antibodies and related reagents | Health Technology |
